Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. [electronic resource]
Producer: 20070816Description: 938-43 p. digitalISSN:- 0340-6245
- Activated Protein C Resistance -- blood
- Administration, Oral
- Blood Coagulation -- drug effects
- Dose-Response Relationship, Drug
- Drug Combinations
- Estradiol -- adverse effects
- Estrogen Receptor Modulators -- administration & dosage
- Estrogen Replacement Therapy -- adverse effects
- Female
- Humans
- Middle Aged
- Norethindrone -- adverse effects
- Norethindrone Acetate
- Norpregnenes -- administration & dosage
- Postmenopause -- metabolism
- Protein C -- metabolism
- Raloxifene Hydrochloride -- administration & dosage
- Selective Estrogen Receptor Modulators -- administration & dosage
- Tablets
- Thromboembolism -- etiology
- Treatment Outcome
- Venous Thrombosis -- etiology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.